Pinnacle Wealth Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
Pinnacle Wealth Management Group's ABBV Position: Q2 2026 in Review
Pinnacle Wealth Management Group increased its AbbVie (ABBV) stake by 0.06% in Q2 2026, buying an estimated $645 and bringing the position to 4,719 shares worth $1.19M. The position accounts for 0.55% of the portfolio, ranked #42.
Pinnacle Wealth Management Group first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.28M in Q1 2022. 926 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Pinnacle Wealth Management Group held 4,719 shares of AbbVie worth $1.19M as of Q2 2026.
- Pinnacle Wealth Management Group bought 3 AbbVie shares in Q2 2026, an estimated $645.
- AbbVie made up 0.55% of Pinnacle Wealth Management Group's portfolio in Q2 2026, its #42 holding.
- Pinnacle Wealth Management Group first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
- Pinnacle Wealth Management Group's AbbVie position peaked at $1.28M in Q1 2022.
- 926 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Pinnacle Wealth Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.